"We conduct clinical research studies for those suffering from Alzheimer's Disease, Parkinson's Disease, MS, Migraine Heachaches."

During the past decade, Infinity Clinical Research, LLC conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 26 clinical trials were completed, i.e. on average, 49.1% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 20 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Infinity Clinical Research, LLC" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "ACADIA Pharmaceuticals Inc." with 3 trials sponsored, "Allergan" with 3 trials sponsored, "Biogen" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Infinity Clinical Research, LLC" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "CoLucid Pharmaceuticals" with 3 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Acorda Therapeutics" with 1 trials as a collaborator and "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Infinity Clinical Research, LLC" are "Alzheimer's Disease" (7 trials), "Alzheimer Disease" (6 trials), "Cervical Dystonia" (3 trials), "Heart Failure" (3 trials) and "Heart Failure With Preserved Ejection Fraction" (3 trials). Many other conditions were trialed in "Infinity Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Infinity Clinical Research, LLC" are "Drug" (56 trials), "Other" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Donanemab" (4 trials), "Aducanumab" (3 trials), "Dihydroergotamine" (3 trials) and "Ocrelizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Infinity Clinical Research, LLC" are 58 trials for "All" genders.

Currently, there are NaN active trials in "Infinity Clinical Research, LLC". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Infinity Clinical Research, LLC, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Infinity Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".